Its protective effect is confirmed in mouse experimental colitis model (Mazmanian et al., 2005; Round and Mazmanian, 2010) and autoimmune encephalomyelitis model (Ochoarepáraz et al., 2010) by increasing the proportion of Foxp3+ regulatory T lymphocytes. The gene discussed is FOXP3; the disease is colitis.